The Predictive Factors Associated with In-Hospital Mortality of Melioidosis: A Cohort Study
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Whitmore, A.S.; Krishnaswami, C.S. An Account of the Discovery of a Hitherto un Described Infective Disease Occurring among the Population of Rangoon. Indian Med. Gaz. 1912, 47, 262–267. [Google Scholar]
- Molyneux, D.H.; Savioli, L.; Engels, D. Neglected tropical diseases: Progress towards addressing the chronic pandemic. Lancet 2017, 389, 312–325. [Google Scholar] [CrossRef] [PubMed]
- Limmathurotsakul, D.; Wongratanacheewin, S.; Day, N.P.; Teerawattanasook, N.; Chaowagul, W.; Chaisuksant, S.; Chetchotisakd, P.; Peacock, S.J.; Wongsuvan, G. Increasing incidence of human melioidosis in northeast Thailand. Am. J. Trop. Med. Hyg. 2010, 82, 1113–1117. [Google Scholar] [CrossRef]
- Hinjoy, S.; Hantrakun, V.; Kongyu, S.; Kaewrakmuk, J.; Wangrangsimakul, T.; Jitsuronk, S.; Saengchun, W.; Bhengsri, S.; Akarachotpong, T.; Thamthitiwat, S.; et al. Melioidosis in Thailand: Present and Future. Trop. Med. Infect. Dis. 2018, 3, 38. [Google Scholar] [CrossRef] [PubMed]
- Domthong, P.; Chaisuksant, S.; Sawanyawisuth, K. What clinical factors are associated with mortality in septicemic melioidosis? A report from an endemic area. J. Infect. Dev. Ctries. 2016, 10, 404–409. [Google Scholar] [CrossRef]
- Churuangsuk, C.; Chusri, S.; Hortiwakul, T.; Charernmak, B.; Silpapojakul, K. Characteristics, clinical outcomes and factors influencing mortality of patients with melioidosis in southern Thailand: A 10-year retrospective study. Asian Pac. J. Trop. Med. 2016, 9, 256–260. [Google Scholar] [CrossRef] [PubMed]
- Zornitzki, L.; Anuk, L.; Frydman, S.; Morag-Koren, N.; Zahler, D.; Freund, O.; Biran, R.; Liron, Y.; Tau, L.; Tchebiner, J.Z.; et al. Rate and predictors of blood culture positivity after antibiotic administration: A prospective single-center study. Infection 2023, 52, 483–490. [Google Scholar] [CrossRef] [PubMed]
- Limmathurotsakul, D.; Peacock, S.J. Melioidosis: A clinical overview. Br. Med. Bull. 2011, 99, 125–139. [Google Scholar] [CrossRef] [PubMed]
- Bhengsri, S.; Peruski, L.F.; Baggett, H.C.; Tanwisaid, K.; Jorakate, P.; Kaewpan, A.; Salika, P.; Naorat, S.; Dejsirilert, S.; Chantra, S.; et al. Incidence of bacteremic melioidosis in eastern and northeastern Thailand. Am. J. Trop. Med. Hyg. 2011, 85, 117–120. [Google Scholar] [CrossRef]
- Bhengsri, S.; Chierakul, W.; Tisayaticom, K.; Thamthitiwat, S.; Chantra, S.; Tanwisaid, K.; Baggett, H.C.; Lertiendumrong, J.; Kaewkungwal, J. Economic burden of bacteremic melioidosis in eastern and northeastern, Thailand. Am. J. Trop. Med. Hyg. 2013, 89, 369–373. [Google Scholar] [CrossRef]
- McLeod, C.; Morris, P.S.; Bauert, P.A.; Kilburn, C.J.; Ward, L.M.; Baird, R.W.; Currie, B.J. Clinical presentation and medical management of melioidosis in children: A 24-Year Prospective study in the Northern Territory of Australia and review of the literature. Clin. Infect. Dis. 2015, 60, 21–26. [Google Scholar] [CrossRef] [PubMed]
- Kingsley, P.V.; Leader, M.; Nagodawithana, N.S.; Tipre, M.; Sathiakumar, N. Melioidosis in Malaysia: A Review of Case Reports. PLoS Neglected Trop. Dis. 2016, 10, e0005182. [Google Scholar] [CrossRef]
- Currie, B.J.; Jacups, S.P.; Cheng, A.C.; Fisher, D.A.; Anstey, N.M.; Huffam, S.E.; Krause, V.L. Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia. Trop. Med. Int. Health 2004, 9, 1167–1174. [Google Scholar] [CrossRef]
- Hassan, M.R.A.; Pani, S.P.; Peng, N.P.; Voralu, K.; Vijayalakshmi, N.; Mehanderkar, R.; Aziz, N.A.; Michael, E. Incidence, risk factors and clinical epidemiology of melioidosis: A complex socio-ecological emerging infectious disease in the Alor Setar region of Kedah, Malaysia. BMC Infect. Dis. 2010, 10, 302. [Google Scholar] [CrossRef]
- Pang, L.; Harris, P.N.; Seiler, R.L.; Ooi, P.L.; Cutter, J.; Goh, K.T.; Cook, A.R.; Fisher, D.; Chai, L.Y.A. Melioidosis, Singapore, 2003–2014. Emerg. Infect. Dis. 2018, 24, 140–143. [Google Scholar] [CrossRef] [PubMed]
- Stewart, J.D.; Smith, S.; Binotto, E.; McBride, W.J.; Currie, B.J.; Hanson, J. The epidemiology and clinical features of melioidosis in Far North Queensland: Implications for patient management. PLoS Neglected Trop. Dis. 2017, 11, e0005411. [Google Scholar] [CrossRef]
- Mardhiah, K.; Wan-Arfah, N.; Naing, N.N.; Hassan, M.R.A.; Chan, H.K. The Cox model of predicting mortality among melioidosis patients in Northern Malaysia: A retrospective study. Medicine 2021, 100, E26160. [Google Scholar] [CrossRef] [PubMed]
- Shaw, T.; Tellapragada, C.; Kamath, A.; Eshwara, V.K.; Mukhopadhyay, C. Implications of environmental and pathogen-specific determinants on clinical presentations and disease outcome in melioidosis patients. PLoS Neglected Trop. Dis. 2019, 13, e0007312. [Google Scholar] [CrossRef]
- Currie, B.J. Melioidosis: An important cause of pneumonia in residents of and travellers returned from endemic regions. Eur. Respir. J. 2003, 22, 542–550. [Google Scholar] [CrossRef]
- Meumann, E.M.; Cheng, A.C.; Ward, L.; Currie, B.J. Clinical features and epidemiology of melioidosis pneumonia: Results from a 21-year study and review of the literature. Clin. Infect. Dis. 2012, 54, 362–369. [Google Scholar] [CrossRef]
- Kirby, P.; Smith, S.; Ward, L.; Hanson, J.; Currie, B.J. Clinical utility of platelet count as a prognostic marker for melioidosis. Am. J. Trop. Med. Hyg. 2019, 100, 1085–1087. [Google Scholar] [CrossRef] [PubMed]
Characteristics | Non-Survival (n = 117) | Survival (n = 145) | p-Value |
---|---|---|---|
Male 1 | 83 (70.4%) | 110 (75.9%) | 0.399 |
Age (years) 2 | 59.3 ± 15.7 | 55.5 ± 13.2 | 0.037 |
Comorbidities (Y/N) 1 | 93 (79.5%) | 116 (80.0%) | 1.000 |
DM 1 | 49 (41.9%) | 74 (51.0%) | 0.171 |
Chronic kidney disease 1 | 18 (15.4%) | 17 (11.7%) | 0.466 |
Cirrhosis 1 | 15 (12.8%) | 16 (11.0%) | 0.703 |
Duration of symptoms (days) 3 | 4 (3–7) | 7 (3–14) | <0.001 |
Clinical syndromes 1 | <0.001 | ||
Localized or bacteremia * | 35 (29.9%) | 77 (53.1%) | |
Disseminated or multifocal | 82 (70.1%) | 68 (46.9%) | |
Fever 1 | 106 (90.6%) | 125 (86.2%) | 0.337 |
Cough 1 | 54 (46.2%) | 41 (28.3%) | 0.003 |
Altered sensorium 1 | 20 (17.1%) | 9 (6.2%) | 0.009 |
BMI (kg/m2) 2 | 20.6 ± 3.7 | 21.7 ± 3.7 | 0.026 |
Systolic blood pressure (mm Hg) 2 | 117.1 ± 27.7 | 125.8 ± 23.3 | 0.006 |
Pulse rate (per minute) 2 | 107.0 ± 24.9 | 97.0 ± 18.2 | <0.001 |
Respiration rate (per minute) 2 | 25.2 ± 4.9 | 21.7 ± 2.7 | <0.001 |
Abnormal chest X-ray 1 | 98 (84.5%) | 64 (44.4%) | <0.001 |
%Neutrophils 2 | 85.9 ± 10.7 | 81.4 ± 10.7 | <0.001 |
HCT (%) 2 | 31.3 ± 7.9 | 33.1 ± 7.1 | 0.061 |
Hb (g/dL) 2 | 10.2 ± 2.6 | 10.8 ± 2.3 | 0.049 |
MCV (fL) 2 | 81.1 ± 9.9 | 80.5 ± 8.7 | 0.608 |
Platelets (/mm3) 3 | 165,000 (93,000–219,000) | 213,000 (159,000–327,000) | <0.001 |
BUN (mg/dL) 3 | 37 (22–59) | 17 (12–28) | <0.001 |
Creatinine (mg/dL) 3 | 1.9 (1.2–3.4) | 1.1 (0.8–1.6) | <0.001 |
AST (U/L) 3 | 107 (63–258) | 53.5 (35–93) | <0.001 |
ALT (U/L) 3 | 56.5 (26–126) | 41 (23–67) | 0.002 |
Albumin (g/dL) 2 | 2.5 ± 0.6 | 2.8 ± 0.6 | <0.001 |
Globulin (g/dL) 2 | 3.4 ± 0.7 | 3.7 ± 0.6 | 0.002 |
Total bilirubin (mg/dL) 3 | 1.7 (0.9–4.0) | 0.9 (0.5–1.7) | <0.001 |
Direct bilirubin (mg/dL) 3 | 1.0 (0.5–2.7) | 0.3 (0.1–0.8) | <0.001 |
Na (mEq/L) 2 | 130.2 ± 6.5 | 130.1 ± 6.0 | 0.936 |
CO2 (mEq/L) 2 | 17.7 ± 6.5 | 22.3 ± 5.6 | <0.001 |
Predictive Factors | Univariable Odds Ratio (95% Confidence Interval) | p-Value | Multivariable Odds Ratio (95% Confidence Interval) | p-Value |
---|---|---|---|---|
Male | 0.78 (0.45–1.35) | 0.369 | 0.56 (0.24–1.30) | 0.176 |
Age | 1.02 (1.00–1.04) | 0.039 | 1.04 (1.01–1.07) | 0.019 |
DM (Y/N) | 0.69 (0.42–1.13) | 0.141 | 0.65 (0.30–1.39) | 0.267 |
Duration of symptoms | 0.96 (0.93–0.99) | 0.005 | 0.98 (0.94–1.03) | 0.398 |
BMI (m/kg2) | 0.92 (0.86–0.99) | 0.028 | 0.97 (0.87–1.08) | 0.532 |
Clinical syndromes | ||||
Localized/bacteremia | base | base | ||
Disseminated | 2.65 (1.59–4.43) | <0.001 | 0.94 (0.40–2.19) | 0.885 |
Systolic blood pressure (mm Hg) | 0.99 (0.98–1.00) | 0.007 | 0.99 (0.97–1.00) | 0.142 |
Respiration rate (/min) | 1.33 (1.21–1.47) | <0.001 | 1.18 (1.06–1.32) | 0.003 |
Abnormal chest X-ray finding 1 | 6.81 (3.74–12.41) | <0.001 | 4.79 (1.98–11.59) | 0.001 |
Platelets (/mm3) | 1.00 (1.00–1.00) | <0.001 | 1.00 (1.00–1.00) | 0.432 |
Creatinine (mg/dL) | 1.24 (1.09–1.42) | <0.001 | 1.00 (0.85–1.18) | 0.995 |
Albumin (g/dL) | 0.43 (0.28–0.66) | <0.001 | 0.91 (0.47–1.76) | 0.778 |
Total bilirubin (mg/dL) | 1.20 (1.07–1.34) | 0.001 | 1.09 (0.97–1.22) | 0.157 |
AST (U/L) | 1.01 (1.00–1.01) | <0.001 | 1.00 (1.00–1.01) | 0.016 |
CO2 (mEq/L) | 0.88 (0.84–0.92) | <0.001 | 0.92 (0.85–0.99) | 0.036 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Chayangsu, S.; Suankratay, C.; Tantraworasin, A.; Khorana, J. The Predictive Factors Associated with In-Hospital Mortality of Melioidosis: A Cohort Study. Medicina 2024, 60, 654. https://doi.org/10.3390/medicina60040654
Chayangsu S, Suankratay C, Tantraworasin A, Khorana J. The Predictive Factors Associated with In-Hospital Mortality of Melioidosis: A Cohort Study. Medicina. 2024; 60(4):654. https://doi.org/10.3390/medicina60040654
Chicago/Turabian StyleChayangsu, Sunee, Chusana Suankratay, Apichat Tantraworasin, and Jiraporn Khorana. 2024. "The Predictive Factors Associated with In-Hospital Mortality of Melioidosis: A Cohort Study" Medicina 60, no. 4: 654. https://doi.org/10.3390/medicina60040654